Skip to main content
Article
A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer
Breast Cancer Research and Treatment (2013)
  • Reshma Mahtani, Baptist Health South Florida
  • Shanu Modi
  • Cristina Saura
  • Charles Henderson
  • Nancy U Lin
  • Jill Goddard
  • Eduardo Rodenas
  • Clifford Hudis, Memorial Sloan Kettering Cancer Center
  • Joyce A. O'Shaughnessy
  • Jose Baselga
Publication Date
April 12, 2013
Citation Information
Reshma Mahtani, Shanu Modi, Cristina Saura, Charles Henderson, et al.. "A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer" Breast Cancer Research and Treatment Vol. 139 (2013) p. 07 - 113
Available at: http://works.bepress.com/reshma-mahtani/76/